BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9149776)

  • 1. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.
    Anderlini P; Przepiorka D; Seong C; Smith TL; Huh YO; Lauppe J; Champlin R; Körbling M
    Transfusion; 1997 May; 37(5):507-12. PubMed ID: 9149776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
    Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
    Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.
    Moncada V; Bolan C; Yau YY; Leitman SF
    Transfusion; 2003 Apr; 43(4):495-501. PubMed ID: 12662283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
    Engelhardt M; Bertz H; Wäsch R; Finke J
    Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield.
    Yu J; Leisenring W; Bensinger WI; Holmberg LA; Rowley SD
    Transfusion; 1999 May; 39(5):442-50. PubMed ID: 10335991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.
    Grigg AP; Roberts AW; Raunow H; Houghton S; Layton JE; Boyd AW; McGrath KM; Maher D
    Blood; 1995 Dec; 86(12):4437-45. PubMed ID: 8541532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
    Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
    Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
    Anderlini P; Donato M; Lauppe MJ; Huh YO; Martin TG; Chan KW; Champlin RE; Körbling M
    Br J Haematol; 2000 Jun; 109(4):770-2. PubMed ID: 10929027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
    Glaspy JA; Shpall EJ; LeMaistre CF; Briddell RA; Menchaca DM; Turner SA; Lill M; Chap L; Jones R; Wiers MD; Sheridan WP; McNiece IK
    Blood; 1997 Oct; 90(8):2939-51. PubMed ID: 9376574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.
    de la Rubia J; Arbona C; de Arriba F; del Cañizo C; Brunet S; Zamora C; Díaz MA; Bargay J; Petit J; de la Serna J; Insunza A; Arrieta R; Pascual MJ; Serrano D; Sanjuan I; Espigado I; Alegre A; Martínez D; Verdeguer A; Martínez C; Benlloch L; Sanz MA;
    Transfusion; 2002 Jan; 42(1):4-9. PubMed ID: 11896306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
    Kozuka T; Ikeda K; Teshima T; Yoshida C; Shinagawa K; Kojima K; Matsuo K; Bessho A; Sunami K; Hiramatsu Y; Maeda Y; Noguchi T; Yamamoto K; Fujii N; Imai T; Kusumoto KK; Masuda K; Takenaka K; Ishimaru F; Niiya K; Koide N; Tanimoto M; Harada M
    Transfusion; 2004 Apr; 44(4):526-32. PubMed ID: 15043568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
    Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
    J Clin Apher; 2001; 16(2):82-7. PubMed ID: 11746533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
    Díaz MA; Sevilla J; de la Rubia J; Verdeguer A; Espigado I; Vicent MG; Pascual MJ; Zamora C; Arrieta R; Serrano D; del Cañizo C; Arbona C; de Arriba F; Bargay J; Brunet S; Sanz MA
    Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
    De la Rubia J; Arbona C; Del Cañizo C; Arrieta R; De Arriba F; Pascual MJ; Sanjuan I; Díaz MA; Brunet S; Alegre A; Insunza A; Espigado I; Zamora C; De la Serna J; Serrano D; Bargay J; Petit J; Martínez D; Verdeguer A; Ribera JM; Martínez C; Benlloch L; Sanz MA
    J Hematother Stem Cell Res; 2002 Aug; 11(4):705-9. PubMed ID: 12201959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.